Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

Nucleic Acids Research(2024)10.1093/nar/gkae547Source: DataRank Database

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer is a research paper published in Nucleic Acids Research (2024). On theSindex it has a DataRank of 0.703. It has been cited 36 times, with 32 citing works in its 1-hop citation network.

N/A

0.703DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access36 citations · 32 citing works in its network

Download PDF

Cite:

Linked data & code

hpa pxd

Data availability

Repositories this paper deposited data in (declared in PubMed).

GEOGSE244025

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (23 grants)Impact (FWCI 11.04)OA: goldTopics (81)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 77%Citation Network 23%

Base Score Contribution

0.542

From this paper's citation signal

Citation Network Contribution

0.161

From 16 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 32 citers.

Integrated multi-omics assessment of lineage plasticity in a prostate cancer patient with brain and dural metastases
npj Precision Oncology20246 citations67 referencesContributes 0.029
Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer
Acta Biochimica et Biophysica Sinica20262 citations38 referencesContributes 0.029
Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer
Oncogene20245 citations82 referencesContributes 0.022
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
Current Oncology Reports20256 citations119 referencesContributes 0.016
An integrated proteomic portrait of prostate cancer progression
Cell Reports20253 citations111 referencesContributes 0.012

Authors (26)

Qian Yang ORCID,Mirja Rotinen ORCID,Rongrong Huang ORCID,Hyo‐Young Kim ORCID,Brad Gallent ORCID

Live enrichment

PubMed:38932701 PMC:PMC11260453 OpenAlex:https://openalex.org/W4400092898

UCLA Prostate Cancer SPORE

Grant: 2P50CA092131

UCLA Prostate Cancer SPORE

Grant: 1R01CA220327

UCLA Prostate Cancer SPORE

Grant: 1R01CA271750

Department of Defense

Grant: PC180541

Department of Defense

Grant: PC190604

Department of Defense

Grant: PC190482

Institute for Prostate Cancer Research

Grant: P50CA97186

Institute for Prostate Cancer Research

Grant: R01CA266452

Institute for Prostate Cancer Research

Grant: R01 CA234715

Institute for Prostate Cancer Research

Grant: R21 CA277368

NCI NIH HHS

Grant: P50 CA092131

NCI NIH HHS

Grant: T32 CA240172

NCI NIH HHS

Grant: P50 CA097186

NCI NIH HHS

Grant: P30 CA016042

NCI NIH HHS

Grant: R01 CA220327

NCI NIH HHS

Grant: R01 CA271750

National Institutes of Health

Grant: 5R01CA266452-04

Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity

National Institutes of Health

Grant: 5R01CA271750-04

Mechanisms of Prostate Cancer Metastasis

National Institutes of Health

Grant: 5P50CA092131-05

UCLA SPORE IN PROSTATE CANCER

National Institutes of Health

Grant: 6R01CA234715-03

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

National Institutes of Health

Grant: 1R21CA277368-01

A Prostate Cancer Dependency Map to Identify Tumor Subtype-Specific Vulnerabilities

National Institutes of Health

Grant: 5P50CA097186-13

Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment

National Institutes of Health

Grant: 2R01CA220327-06

Racial Difference in Prostate Cancer

FWCI

11.04

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://doi.org/10.1093/nar/gkae547

publisherhttps://doi.org/10.1093/nar/gkae547

publisherhttps://academic.oup.com/nar/article-pdf/52/13/7740/58550025/gkae547.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38932701

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11260453

Fields of Study

Prostate Cancer Treatment and ResearchCancer-related gene regulationRNA Research and Splicing0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AdenocarcinomaAnimalsBenzamidesHumansMaleNerve Tissue ProteinsNitrilesPhenylthiohydantoinProstatic NeoplasmsReceptors, AndrogenReceptors, GlucocorticoidGene Expression Regulation, NeoplasticRNA-Binding ProteinsNeuroendocrine TumorsDrug Resistance, NeoplasmCell LineageEpigenesis, GeneticCell Line, TumorMice

Keywords

BiologyReprogrammingEnzalutamideCancer researchEpigeneticsProstate cancerChromatinLineage (genetic)Androgen receptorChromatin immunoprecipitationGeneticsCancerGeneGene expressionPromoterMaleMedical SciencesDrug Resistance610DiseasesONECUT2Nerve Tissue ProteinsAdenocarcinomaAndrogenCell LineEpigenesis, GeneticMiceGlucocorticoidReceptors, GlucocorticoidGeneticNeoplasmsCell Line, TumorReceptorsNitrilesPhenylthiohydantoinMedical SpecialtiesMedicine and Health Sciencesprostate cancer; OneCut2; lineage plasticityHumansAnimalsCell LineageNeoplasticTumorProstatic NeoplasmsRNA-Binding ProteinsGenomicsGene Expression Regulation, NeoplasticNeuroendocrine TumorsGene Expression RegulationOncologyReceptors, AndrogenDrug Resistance, NeoplasmBenzamidesNeoplasmHormonal therapyEpigenesis

Sustainable Development Goals

SDG 0: Good health and well-being